推出CAR T-细胞疗法:超越CRS和ICANS,解决延迟并发症并优化管理策略
1From The University of Texas MD Anderson Cancer Center, Houston, Texas.
Journal of the advanced practitioner in oncology
|February 24, 2025
概括
化学抗原受体 (CAR) T细胞疗法是血液癌症的突破,但它会导致独特的毒性. 医疗保健提供者必须认识到并管理这些对患者安全的不利影响.
科学领域:
- 在瘤学瘤学.
- 免疫治疗是一种免疫疗法.
- 血液学 血液学 血液学
背景情况:
- 化学抗原受体 (CAR) T细胞疗法在治疗复发性/耐药性血液性恶性瘤方面取得了重大进展.
- 经FDA批准的CAR T细胞疗法针对特定的B细胞恶性瘤,包括非霍奇金淋巴瘤,多发性骨髓瘤和B细胞急性淋巴细胞白血病.
研究的目的:
- 突出高级实践提供者在管理CAR T细胞治疗毒性的关键作用.
- 强调需要识别和减轻与CAR T细胞治疗相关的独特不良影响.
主要方法:
- 对血液恶性瘤中CAR-T细胞治疗的II期临床试验的审查.
- 报告的毒性和不良事件的分析.
- 对先进实践提供商的管理策略进行讨论.
主要成果:
- 卡尔T细胞疗法在治疗各种血液癌症方面取得了显著的成功.
- 这种疗法与显著的毒性和不良影响的独特模式有关.
- 识别和管理这些毒性对于患者的治疗结果至关重要.
结论:
- 高级实践提供者对于接受CAR T细胞治疗的患者的多学科护理至关重要.
- 识别和管理与CAR T细胞相关的毒性方面的专业知识对于有效的患者护理至关重要.
- 积极管理不良反应可以提高患者的安全性和治疗疗效.
相关概念视频
Tumor Immunotherapy
463
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
463
Cystic Fibrosis: Management
138
Cystic fibrosis (CF) is an autosomal recessive disorder that predominantly affects individuals of Northern European descent, occurring at a rate of 1 in 3500. It is caused by a genetic mutation in a gene on chromosome 7, most commonly the ΔF508 mutation, that codes for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. This results in thicker mucus secretions and obstruction pathologies in multiple organs, including the lungs and sinuses.
Sinus disease and chronic...
Sinus disease and chronic...
138
Cytotoxic T Cells-mediated Immune Response
826
Cytotoxic T cells are a vital component of the immune system. They have the remarkable ability to identify and target antigens on infected or abnormal cells. These antigens often originate from intracellular pathogens such as viruses or abnormal proteins cancer cells produce.
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
826
T Cell Activation and Clonal Selection
627
T cells are integral to our adaptive immune system, recognizing and effectively responding to foreign antigens. T cell activation and clonal selection are pivotal in orchestrating this immune response. This article elucidates these mechanisms, detailing the roles of cluster of differentiation (CD) markers, major histocompatibility complex (MHC) molecules, costimulatory signals, and the process of clonal selection.
Naive T cells that have not yet encountered an antigen express two primary CD...
Naive T cells that have not yet encountered an antigen express two primary CD...
627
Cell-mediated Immune Responses
66.7K
Overview
66.7K
![Dynamic Imaging of Chimeric Antigen Receptor T Cells with [18F]Tetrafluoroborate Positron Emission Tomography/Computed Tomography](/_next/image?url=https%3A%2F%2Fcloudfront.jove.com%2FCDNSource%2Fteasers%2F62334.jpg&w=3840&q=50)

